Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans

Background & Aims: Inflammatory bowel disease (IBD) has familial aggregation in African Americans (AAs), but little is known about the molecular genetic susceptibility. Mapping studies using the Immunochip genotyping array expand the number of susceptibility loci for IBD in Caucasians to 163, but the contribution of the 163 loci and European admixture to IBD risk in AAs is unclear. We performed a genetic mapping study using the Immunochip to determine whether IBD susceptibility loci in Caucasians also affect risk in AAs and identify new associated loci.

Methods: We recruited AAs with IBD and without IBD (controls) from 34 IBD centers in the United States; additional controls were collected from 4 other Immunochip studies. Association and admixture loci were mapped for 1088 patients with Crohn's disease, 361 with ulcerative colitis, 62 with IBD type unknown, and 1797 controls; 130,241 autosomal single-nucleotide polymorphisms (SNPs) were analyzed.

Results: The strongest associations were observed between ulcerative colitis and HLA rs9271366 (P = 7.5 × 10(-6)), Crohn's disease and 5p13.1 rs4286721 (P = 3.5 × 10(-6)), and IBD and KAT2A rs730086 (P = 2.3 × 10(-6)). Additional suggestive associations (P < 4.2 × 10(-5)) were observed between Crohn's disease and IBD and African-specific SNPs in STAT5A and STAT3; between IBD and SNPs in IL23R, IL12B, and C2orf43; and between ulcerative colitis and SNPs near HDAC11 and near LINC00994. The latter 3 loci have not been previously associated with IBD, but require replication. Established Caucasian associations were replicated in AAs (P < 3.1 × 10(-4)) at NOD2, IL23R, 5p15.3, and IKZF3. Significant admixture (P < 3.9 × 10(-4)) was observed for 17q12-17q21.31 (IZKF3 through STAT3), 10q11.23-10q21.2, 15q22.2-15q23, and 16p12.2-16p12.1. Network analyses showed significant enrichment (false discovery rate <1 × 10(-5)) in genes that encode members of the JAK-STAT, cytokine, and chemokine signaling pathways, as well those involved in pathogenesis of measles.

Conclusions: In a genetic analysis of 3308 AA IBD cases and controls, we found that many variants associated with IBD in Caucasians also showed association evidence with these diseases in AAs; we also found evidence for variants and loci not previously associated with IBD. The complex genetic factors that determine risk for or protection against IBD in different populations require further study.

Citing Articles

Mendelian randomization study of inflammatory bowel disease and type 1 diabetes.

Zhu J, Ma X, Liu M, Ma L, Sun X, Yan M Endocrine. 2024; 86(3):943-953.

PMID: 39083171 DOI: 10.1007/s12020-024-03919-9.

Differential Manifestations of Inflammatory Bowel Disease Based on Race and Immigration Status.

Khalessi A, Crowe B, Xia Y, Rubinfeld G, Baylor J, Radin A Gastro Hep Adv. 2024; 3(3):326-332.

PMID: 38765199 PMC: 11101196. DOI: 10.1016/j.gastha.2023.11.021.

Transcriptome-wide association studies associated with Crohn's disease: challenges and perspectives.

Jia K, Shen J Cell Biosci. 2024; 14(1):29.

PMID: 38403629 PMC: 10895848. DOI: 10.1186/s13578-024-01204-w.

multi-GPA-Tree: Statistical approach for pleiotropy informed and functional annotation tree guided prioritization of GWAS results.

Khatiwada A, Yilmaz A, Wolf B, Pietrzak M, Chung D PLoS Comput Biol. 2023; 19(12):e1011686.

PMID: 38060592 PMC: 10729974. DOI: 10.1371/journal.pcbi.1011686.

Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review.

Choudhury A, Dhillon J, Sekar A, Gupta P, Singh H, Sharma V BMC Gastroenterol. 2023; 23(1):246.

PMID: 37468869 PMC: 10354965. DOI: 10.1186/s12876-023-02887-0.

References

Okada Y, Yamazaki K, Umeno J, Takahashi A, Kumasaka N, Ashikawa K . HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology. 2011; 141(3):864-871.e1-5. DOI: 10.1053/j.gastro.2011.05.048. View

Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B . Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 2008; 37(Database issue):D619-22. PMC: 2686536. DOI: 10.1093/nar/gkn863. View

Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson T, Kumasaka N . A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. Gastroenterology. 2012; 144(4):781-8. DOI: 10.1053/j.gastro.2012.12.021. View

Wang M, Okazaki T, Kugathasan S, Cho J, Isaacs K, Lewis J . Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis. 2012; 18(12):2277-87. PMC: 3810419. DOI: 10.1002/ibd.22931. View

Ruiz-Narvaez E, Fraser P, Palmer J, Cupples L, Reich D, Wang Y . MHC region and risk of systemic lupus erythematosus in African American women. Hum Genet. 2011; 130(6):807-15. PMC: 3215804. DOI: 10.1007/s00439-011-1045-2. View

Price A, Patterson N, Plenge R, Weinblatt M, Shadick N, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38(8):904-9. DOI: 10.1038/ng1847. View

Parkes M, Cortes A, van Heel D, Brown M . Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet. 2013; 14(9):661-73. DOI: 10.1038/nrg3502. View

Adeyanju O, Okou D, Huang C, Kumar A, Sauer C, Galloway C . Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture. Inflamm Bowel Dis. 2012; 18(12):2357-9. PMC: 3392535. DOI: 10.1002/ibd.22944. View

Simon J, Lin F, Hulley S, Blanche P, Waters D, Shiboski S . Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol. 2006; 97(6):843-50. DOI: 10.1016/j.amjcard.2005.09.134. View

10.

Fowler S, Ananthakrishnan A, Gardet A, Stevens C, Korzenik J, Sands B . SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. J Crohns Colitis. 2014; 8(8):845-51. PMC: 4237062. DOI: 10.1016/j.crohns.2014.01.003. View

11.

Cortes A, Brown M . Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011; 13(1):101. PMC: 3157635. DOI: 10.1186/ar3204. View

12.

Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D . Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007; 3(4):e58. PMC: 1853118. DOI: 10.1371/journal.pgen.0030058. View

13.

Patterson N, Hattangadi N, Lane B, Lohmueller K, Hafler D, Oksenberg J . Methods for high-density admixture mapping of disease genes. Am J Hum Genet. 2004; 74(5):979-1000. PMC: 1181990. DOI: 10.1086/420871. View

14.

Hirano A, Yamazaki K, Umeno J, Ashikawa K, Aoki M, Matsumoto T . Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis. 2013; 19(3):526-33. DOI: 10.1097/MIB.0b013e31828075e7. View

15.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

16.

Wang Y, Loftus Jr E, Cangemi J, Picco M . Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013; 88(1):20-5. DOI: 10.1159/000350759. View

17.

Knights D, Lassen K, Xavier R . Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut. 2013; 62(10):1505-10. PMC: 3822528. DOI: 10.1136/gutjnl-2012-303954. View

18.

Chen G, Millikan R, John E, Ambrosone C, Bernstein L, Zheng W . The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data. PLoS Genet. 2010; 6(9):e1001096. PMC: 2932740. DOI: 10.1371/journal.pgen.1001096. View

19.

Dassopoulos T, Nguyen G, Bitton A, Bromfield G, Schumm L, Wu Y . Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis. 2007; 13(8):975-83. DOI: 10.1002/ibd.20144. View

20.

Hong S, Park C, Park S, Lee C, Ye B, Kim Y . Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants. Gut. 2015; 65(5):788-96. DOI: 10.1136/gutjnl-2014-308617. View